(Q34671104)

English

A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

obsessive-compulsive disorder

0 references

behavior therapy

1 reference

based on heuristic

inferred from title

cognitive behavioral therapy

1 reference

based on heuristic

inferred from title

6

object named as

Eric A Storch

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

5

object named as

Tanya K Murphy

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Joseph F McGuire

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

John Piacentini

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Adam B Lewin

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Erin A Brennan

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

30 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Depression and Anxiety

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

580-593

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Cognitive behavior therapy for obsessive-compulsive and related disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Treating trichotillomania: a meta-analysis of treatment effects and moderators for behavior therapy and serotonin reuptake inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)--a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Family-based exposure and response prevention therapy for preschool-aged children with obsessive-compulsive disorder: a pilot randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Meta-analysis and moderator analysis: can the field develop further?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Evidence base update for psychosocial treatments for pediatric obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Synthesizing evidence: shifting the focus from individual studies to the body of evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Family accommodation in obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

The Leyton Obsessional Inventory-Child Version Survey Form does not demonstrate adequate psychometric properties in American youth with pediatric obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Predictors and Moderators of Treatment Outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Estimating the size of treatment effects: moving beyond p values

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Predictors of treatment response in pediatric obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

SSRI adverse events: how to monitor and manage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Benefits of cognitive-behavioural therapy for children and youth with obsessive-compulsive disorder: re-examination of the evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Cognitive behavioral treatment for young children with obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

The epidemiology of obsessive-compulsive disorder in children and adolescents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

7 July 2018

2 references

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

https://api.crossref.org/works/10.1002%2FDA.22389

7 January 2021

based on heuristic

inferred from DOI database lookup

A family study of obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Functional impairment in childhood OCD: development and psychometrics properties of the Child Obsessive-Compulsive Impact Scale-Revised (COIS-R).

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Preliminary investigation of web-camera delivered cognitive-behavioral therapy for youth with obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

A meta-analysis of behavior therapy for Tourette Syndrome

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

21 January 2018

Defining treatment response and remission in obsessive-compulsive disorder: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

26 October 2018

An open trial and discontinuation study of fluoxetine in children and adolescents with obsessive-compulsive disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515191

26 October 2018

A randomised controlled trial of cognitive behavioural treatment for obsessive compulsive disorder in children and adolescents

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive-behavioral family treatment for childhood obsessive-compulsive disorder: a 7-year follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of considering parent's preferences when planning treatment for their children--the case of childhood obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

7 January 2021

based on heuristic

inferred from DOI database lookup

Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

7 January 2021

based on heuristic

inferred from DOI database lookup

The effectiveness of treatment for pediatric obsessive-compulsive disorder: A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

7 January 2021

based on heuristic

inferred from DOI database lookup

Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

7 January 2021

based on heuristic

inferred from DOI database lookup

Introduction to Meta-Analysis

1 reference

https://api.crossref.org/works/10.1002%2FDA.22389

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DA.22389

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

release_zobjijkgofchhbcl7m36mfchwu

1 reference

https://api.fatcat.wiki/v0/release/zobjijkgofchhbcl7m36mfchwu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34671104&oldid=1966349035"